Cargando...
Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9
Clustered regularly interspaced short palindromic repeat (CRISPR) RNAs and their associated effector (Cas) enzymes are being developed into promising therapeutics to treat disease. However, CRISPR-Cas enzymes might produce unwanted gene editing or dangerous side effects. Drug-like molecules that can...
Gardado en:
| Publicado en: | Nucleic Acid Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6555185/ https://ncbi.nlm.nih.gov/pubmed/30990769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/nat.2018.0758 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|